You searched for "funding"
RCOphth: Introduction to Ophthalmic Surgery course - 111125
The Royal College of Ophthalmologists: Introduction to Ophthalmic Surgery courseRCOphth: Introduction to Ophthalmic Surgery course - 041225
The Royal College of Ophthalmologists: Introduction to Ophthalmic Surgery courseRCOphth: Introduction to Ophthalmic Surgery course - 051225
The Royal College of Ophthalmologists: Introduction to Ophthalmic Surgery courseRCOphth Introduction to Ophthalmic Surgery courses Feb 26
The Royal College of Ophthalmologists Introduction to Ophthalmic Surgery courseXXI SARCS (State of the Art Refractive Cataract Surgery) Symposium 2023
You are invited to XXI State of the Art Refractive and Cataract Surgery Symposium on Friday 16 June 2023 at the University of Hull. This is the place where brilliant minds from around the world come together to share their...In conversation with Emilio Torres-Netto
We chat to Emilio Torres-Netto from the ELZA Institute, Zurich, Switzerland at ESCRS 2019 about winning the ICO-Allergan Research Fellowship in 2018 and his research. Click the image below to see his answers to our questions.
Narrative literature review for intermittent exotropia
This is a narrative literature review on prevalence, terminology, risk factors, natural history and clinical characteristics for intermittent exotropia. A Medline search was conducted with no date restrictions up to September 2020 and collating English language studies. Prevalence was reported...Professor Roy Taylor awarded MBE for services to diabetes research
Congratulations to Diabetes UK-funded researcher Professor Roy Taylor, who has been awarded an MBE in the New Year Honours list, recognising his world-leading work in diabetes research.
Ranibizumab versus laser in diabetic macular oedema (LUCIDATE study)
The aim of this study was to compare the functional and structural effects of Ranibizumab versus macular laser treatment in patients with diabetic macular oedema. It was a single centre, prospective, randomised, single masked clinical trial spanning a 48 week...
Macular atrophy with aflibercept
The authors of this paper set out to investigate the prevalence of macular atrophy in treatment-naive patients with neovascular AMD undergoing aflibercept monotherapy (three monthly loading injections followed by subsequent treatment every two months). Case notes over a three year...
